• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Fluorescent Augmentation of Bile Ducts\’ Visualization at Laparoscopic Cholecystectomy By Using Fluorescein and Ultraviolet Generating and Conducting Device

Fluorescent Augmentation of Bile Ducts\’ Visualization at Laparoscopic Cholecystectomy By Using Fluorescein and Ultraviolet Generating and Conducting Device

Objective and background
The purpose of this new technique is to improve visualization of the extrahepatic bile ducts at laparoscopic cholecystectomy. The idea depends on the fact that intravenously-administered fluorescein is excreted by the liver and its concentration in bile reaches 500 times that of plasma. Ultraviolet A (UVA) excites fluorescein and causes it to emit green light.

Method:
Animal study. Twelve New Zealand rabbits had laparotomy under general anesthesia and were intravenously injected with fluorescein at a dose of 7.5mg/kg. The room light was reduced and ultraviolet light at 365nm wavelength was cast on the gall bladder and bile ducts area. The clarity of biliary topography under this light was visually observed.
Human study. Seven patients who had symptomatic gallstones underwent laparoscopic cholecystectomies that were guided by this technique. After induction of pneumoperitoneum intravenous 500mg fluorescein was administered. Ultraviolet A (wavelength 365nm) from a LED light source was used to induce fluorescence of bile. It was delivered by a rod-like device that was designed and built by the authors. The device was introduced through the epigastric trocar. Ultraviolet visualization was used at three occasions during each procedure; before dissection of Callot’s triangle, before clipping of the cystic duct and at the end of the procedure in order to look for possible bile leaks. At each occasion the conventional white light transmitted through the telescope was reduced to 20-30% of its intensity.

Results:
Animal study. In all rabbits the extrahepatic biliary topography was clearly delineated by the shining green light of the excited fluorescein in bile. Vessels were clearly distinguished from bile ducts.
Human study. Within four to five minutes the bile ducts were shining with green fluorescence, which distinguished them from the surrounding tissues. In all cases identification of the extrahepatic biliary anatomy by the fluorescence technique preceded its identification with the conventional white light. Fluorescence remained for the whole duration of operation that extended for 40-82 minutes.
The total ultraviolet energy exposure was calculated to range from 0.6-1.8J/cm2. This is far less than the maximum safe permissible daily exposure of 15J/cm2 that was set by The American Conference of Governmental Industrial Hygienists.

Conclusions: At laparoscopic cholecystectomy intravenous fluorescein injection and ultraviolet A excitation induce bile ducts fluorescence. The technique allows better and earlier real time visualization of biliary anatomy than with the conventional white light. The technique is safe, simple and inexpensive. It serves as an additional tool that would improve safety of laparoscopic cholecystectomy.

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search